WallStreetZenWallStreetZen

NYSE: FMS
Fresenius Medical Care Ag Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their FMS stock forecasts and price targets.

Forecast return on equity

Is FMS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.5%

Forecast return on assets

Is FMS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

FMS revenue forecast

What is FMS's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$21.4B-0.89%
Avg 2 year Forecast
$22.2B+2.87%
Avg 3 year Forecast
$22.9B+6.1%
FMS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FMS earnings growth forecast

How is FMS forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
63.02%
Industry
15.41%
Market
21.77%
FMS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
FMS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
FMS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

FMS revenue growth forecast

How is FMS forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
3.18%
Industry
6.24%
Market
10.16%
FMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FMS vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
FMS$21.48N/AN/A
DVA$133.91$137.67+2.81%Buy
UHS$164.91$186.80+13.27%Buy
THC$97.86$103.75+6.02%Strong Buy
CHE$616.51$681.00+10.46%Buy
View Top Medical Care Facility Stocks

Fresenius Medical Care Ag Stock Forecast FAQ

What is FMS's revenue growth forecast for 2024-2026?

(NYSE: FMS) Fresenius Medical Care Ag's forecast annual revenue growth rate of 3.18% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Fresenius Medical Care Ag's revenue in 2024 is $20,917,867,741.On average, 3 Wall Street analysts forecast FMS's revenue for 2024 to be $6,285,704,186,104, with the lowest FMS revenue forecast at $6,254,436,288,498, and the highest FMS revenue forecast at $6,342,290,143,397. On average, 3 Wall Street analysts forecast FMS's revenue for 2025 to be $6,524,448,841,286, with the lowest FMS revenue forecast at $6,489,935,790,934, and the highest FMS revenue forecast at $6,588,343,727,594.

In 2026, FMS is forecast to generate $6,728,871,164,858 in revenue, with the lowest revenue forecast at $6,728,871,164,858 and the highest revenue forecast at $6,728,871,164,858.

If you're new to stock investing, here's how to buy Fresenius Medical Care Ag stock.

What is FMS's forecast return on assets (ROA) for 2024-2027?

(NYSE: FMS) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of N/A.

What is FMS's forecast return on equity (ROE) for 2024-2027?

(NYSE: FMS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.